The neuropsychology of normal aging and preclinical Alzheimer’s disease

BACKGROUND: An NIA-sponsored workgroup on preclinical Alzheimer’s disease (AD) articulated the need to characterize cognitive differences between normal aging and preclinical AD. METHODS: 71 apolipoprotein E (APOE) e4 homozygotes (HMZ), 194 e3/4 heterozygotes (HTZ), and 356 e4 noncarriers (NC) aged...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Caselli, Richard J., Locke, Dona E.C., Dueck, Amylou C., Knopman, David S., Woodruff, Bryan K., Hoffman-Snyder, Charlene, Rademakers, Rosa, Fleisher, Adam S., Reiman, Eric M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3700591/
https://ncbi.nlm.nih.gov/pubmed/23541188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2013.01.004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares